Search Results 1051-1060 of 24304 for B cell lymphomas

  1. Medical Research & Education - Mayo Clinic News Network

    ... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. In the Loop ...

  2. Hematology - Doctors - Mayo Clinic

    ... cell therapy, Multiple myeloma, Myelodyspla...stic syndromes, B-cell lymphoma, Lymphoma, Burkitt lymphoma, Follicular lymphoma, Leukemia. Show more areas of ...

  3. Clinical trials - Oncology (Medical)

    Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato ...

  4. - Doctors and Medical Staff - Mayo Clinic

    In his free time, Dr. Kharfan-Dabaja enjoys traveling and reading. Conditions treated · Acute myelogenous leukemia · Aplastic anemia · B-cell lymphoma · Chronic ...

  5. Nausea and vomiting - Mayo Clinic

    Diffuse large B-cell lymphoma · Diffuse midline glioma (DMG) · Diverticulitis · Drug allergy · Dumping syndrome · Dysphagia · E. coli · Ear infection (middle ...

  6. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

    D. Rochester, MN. Area of Focus: Bone marrow transplant, CAR-T cell therapy, B-cell lymphoma, Lymphoma, Burkitt lymphoma, Follicular lymphoma, Hodgkin lymphoma ...

  7. Clinical trials - Oncology (Medical)

    Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Eau Claire, Wis., La Crosse, Wis ...

  8. Medical Research & Education - Mayo Clinic News Network

    ... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. In the Loop ...

  9. Spinal cord tumor - Doctors and departments - Mayo Clinic

    active Find a doctor whose last name begins with the letter B B ... cell lymphoma, Glioblastoma, Lymphoma, Glioma ... Anyone had actinic keratosis turn into ...

  10. A Study To Investigate Safety And Effectiveness Of BGB-16673 In Combination With Other Agents In Participants With Relapsed Or Refractory B-Cell Malignancies - Mayo Clinic

    * Prior treatment with a B-cell lymphoma-2 (Bcl-2) inhibitor * Substudy 2 Exclusion Criterion: * Participants who discontinued prior zanubrutinib treatment ...